Repligen Corp. (RGEN)
179.05
+5.56
(+3.20%)
USD |
NASDAQ |
Nov 09, 16:00
179.05
0.00 (0.00%)
After-Hours: 17:58
Repligen Gross Profit (Annual) : 350.64M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 350.64M |
| December 31, 2024 | 284.00M |
| December 31, 2023 | 277.27M |
| December 31, 2022 | 428.62M |
| December 31, 2021 | 372.95M |
| December 31, 2020 | 194.36M |
| December 31, 2019 | 138.22M |
| December 31, 2018 | 96.92M |
| December 31, 2017 | 67.97M |
| December 31, 2016 | 57.42M |
| December 31, 2015 | 46.69M |
| December 31, 2014 | 35.53M |
| December 31, 2013 | 41.98M |
| December 31, 2012 | 35.10M |
| December 31, 2011 | 22.45M |
| March 31, 2010 | 15.46M |
| Date | Value |
|---|---|
| March 31, 2009 | 22.58M |
| March 31, 2008 | 13.14M |
| March 31, 2007 | 10.46M |
| March 31, 2006 | 9.360M |
| March 31, 2005 | 5.472M |
| March 31, 2004 | 3.666M |
| March 31, 2003 | 4.291M |
| March 31, 2002 | 2.309M |
| March 31, 2001 | 0.8553M |
| March 31, 2000 | 1.871M |
| March 31, 1999 | 1.689M |
| March 31, 1998 | 1.68M |
| March 31, 1997 | 2.996M |
| March 31, 1996 | 4.642M |
| March 31, 1995 | 11.38M |
| March 31, 1994 | 19.16M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Anika Therapeutics, Inc. | 63.81M |
| Precigen, Inc. | 3.588M |
| Agilent Technologies, Inc. | 3.648B |
| Azenta, Inc. | 270.28M |
| Danaher Corp. | 14.55B |